Minerva Neurosciences
NERV
61 hedge funds and large institutions have $235M invested in Minerva Neurosciences in 2026 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 8 closing their positions.
378% more capital inflows, than outflows
Capital inflows: $56M | Capital outflows: $11.7M
200% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 8
67% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 9
30% more funds holding
Funds holding: 47 → 61 (+14)
2.34% more ownership
Funds ownership: 88.5% → 90.84% (+2.3%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$8.76M |
| 2 |
SFCM
Seven Fleet Capital Management
Mountain View,
California
|
+$4.08M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.45M |
| 4 |
ABG
Ally Bridge Group
New York
|
+$2.82M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DV Trading
Chicago,
Illinois
|
-$5.36M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$2.4M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$1.32M |
| 4 |
Millennium Management
New York
|
-$947K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$718K |
NERV Hedge Fund Activity: Q2 2026 in Review
61 of the 8,362 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q2 2026, worth a combined $235M — up 1.7% from $231M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new NERV positions and 8 closed out — a net gain of 16 holders — while 15 added to existing stakes and 9 trimmed.
The largest buyer was BlackRock, adding an estimated $8.76M. The largest seller was DV Trading, exiting entirely with an estimated $5.36M sold.
- 61 institutional investors held Minerva Neurosciences (NERV) as of Q2 2026, up from 47 in Q1 2026.
- Funds reported $235M of Minerva Neurosciences stock for Q2 2026, up 1.7% quarter-over-quarter.
- 24 funds opened new Minerva Neurosciences positions in Q2 2026 and 8 closed out, a net change of +16 holders.
- The largest Minerva Neurosciences buyer in Q2 2026 was BlackRock, an estimated $8.76M added.
- The largest Minerva Neurosciences seller in Q2 2026 was DV Trading, an estimated $5.36M sold.
Based on aggregated 13F filings for Q2 2026.